Felipe Antonio de Oliveira Garcia

Felipe Antonio de Oliveira Garcia

Auto-generated profile, based on publicly available information

Felipe Antonio de Oliveira Garcia

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784-400, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Cold Spring Harbor Molecular Case Studies
Verified
Journal Article
Open access
PDF file
FGFelipe Antonio de Oliveira Garcia
Felipe Antonio de Oliveira Garcia
AEAdriane Evangelista
Adriane Evangelista
BMBRUNA MINNITI MANÇANO
BRUNA MINNITI MANÇANO
DMDaniel Antunes Moreno
Daniel Antunes Moreno
GBGustavo Noriz Berardinelli
Gustavo Noriz Berardinelli
RRRui M. Reis
Rui M. Reis
Choroid plexus tumors (CPTs) are rare intracranial neoplasms, representing <1% of all brain tumors, yet they represent 20% of first-year pediatric brain tumors. Although these tumors have been linked toTP53germline mutations in the context of Li–Fraumeni syndrome, their somatic driver alterations remain poorly understood. In this study, we report two cases of lateral ventricle tumors: 3-yr-old male diagnosed with an atypical choroid plexus papilloma (aCPP), and a 6-mo-old female diagnosed with a choroid plexus carcinoma (CPC). We performed whole-exome sequencing of paired blood and tumor tissue in both patients, categorized somatic variants, and determined copy-number alterations. Our analysis revealed a tier II variant (Association for Molecular Pathology [AMP] criteria) inBRD1,aH3andTP53acetylation agent, in the aCPP. In addition, we detected copy-number gains on Chromosomes 12, 18, and 20 and copy-number losses on Chromosomes 13q and 22q (BRD1locus) in this tumor. The CPC tumor had only a pathogenic germlineTP53variant, based on American College of Medical Genetics (ACMG) criteria, with a clinical and familiar history of Li–Fraumeni syndrome. The CPC patient presented loss of heterozygosity (LoH) ofTP53loci and hyperdiploid genome. Both tumors were microsatellite-stable. This is the first study performing whole-exome sequencing in Brazilian choroid plexus tumors, and in line with the literature, we corroborate the absence of recurrent somatic mutations in these tumors. Further studies with larger sample sizes are necessary to confirm our findings and better understand the underlying biology of these tumors.